What question did this study set out to answer?

This review aims to synthesize evidence on how the gut microbiome affects cancer drug responses and outcomes.

Microbiome Drug Interactions in Cancer Pharmacology: Mechanisms and Therapeutic Opportunities

View Full Paper

Ask AI

Bookmark

Authors

Narrative review highlights microbiome influence on anticancer therapies, suggesting new precision oncology strategies.

This review aims to synthesize evidence on how the gut microbiome affects cancer drug responses and outcomes.
Conducted structured literature search across multiple databases including PubMed and Scopus
Focused on studies from 2005-2025 on microbiome-drug interactions
Analyzed both preclinical and clinical data regarding pharmacokinetics and immune impacts
Favorable microbiome profiles correlate with improved immunotherapy outcomes (HR for survival ~0.5 to 0.7)
Prior antibiotic exposure reduces therapeutic response rates by 20-40%
Microbiome-targeted interventions restored responses in 30-40% of refractory cases in early studies

Patel et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Narrative review highlights microbiome influence on anticancer therapies, suggesting new precision oncology strategies.

This review aims to synthesize evidence on how the gut microbiome affects cancer drug responses and outcomes.
Conducted structured literature search across multiple databases including PubMed and Scopus
Focused on studies from 2005-2025 on microbiome-drug interactions
Analyzed both preclinical and clinical data regarding pharmacokinetics and immune impacts
Favorable microbiome profiles correlate with improved immunotherapy outcomes (HR for survival ~0.5 to 0.7)
Prior antibiotic exposure reduces therapeutic response rates by 20-40%
Microbiome-targeted interventions restored responses in 30-40% of refractory cases in early studies

Patel et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark